Cell and gene therapy landscape in respiratory diseases and future outlook
This trend has led to the development of CGTs shifting from the US and EU to APAC.
Healthcare
Gyre completes Phase III Pirfenidone trial enrolment for pneumoconiosis
Oticara’s nasal cream shows symptom improvement in Phase II trial
Sirius and CRISPR dose first subject in trial of thromboembolic disorders therapy
What’s been agreed at this year’s World Health Assembly?
Centenarians – unlocking the secrets of living to 100
MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study
Charting the road to operational success in clinical trials
